HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara Colombetti Selected Research

Antibodies

1/2020Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity.
10/2018CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sara Colombetti Research Topics

Disease

16Neoplasms (Cancer)
03/2024 - 01/2006
2Hematologic Neoplasms (Hematological Malignancy)
12/2019 - 10/2018
2Melanoma (Melanoma, Malignant)
07/2012 - 01/2006
1Lymphoma (Lymphomas)
03/2024
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024
1Glioblastoma (Glioblastoma Multiforme)
10/2022
1Persistent Infection
10/2022
1Disease Progression
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
11/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020

Drug/Important Bio-Agent (IBA)

5Bispecific AntibodiesIBA
01/2024 - 12/2019
5cibisatamabIBA
01/2021 - 01/2016
4AntigensIBA
10/2022 - 01/2006
4Carcinoembryonic AntigenIBA
01/2021 - 01/2016
3CytokinesIBA
10/2022 - 01/2021
2AntibodiesIBA
01/2020 - 10/2018
1glofitamabIBA
03/2024
1Azacitidine (5 Azacytidine)FDA Link
01/2024
1venetoclaxIBA
01/2024
1ErbB Receptors (EGF Receptor)IBA
10/2022
1epidermal growth factor receptor VIIIIBA
10/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2022
1InterleukinsIBA
10/2022
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1N- propyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (PPTP)IBA
01/2021
1atezolizumabIBA
11/2020
1Blocking AntibodiesIBA
11/2020
1Granzymes (Granzyme)IBA
12/2019
1Proteins (Proteins, Gene)FDA Link
12/2019
1Neoplasm Antigens (Tumor Antigens)IBA
12/2019
1obinutuzumabIBA
10/2018
1Immunoglobulin G (IgG)IBA
01/2016

Therapy/Procedure

5Immunotherapy
01/2021 - 01/2006
3Therapeutics
01/2021 - 07/2012
1Investigational Therapies (Experimental Therapy)
01/2021
1Aftercare (After-Treatment)
09/2016